This clinical trial aims to investigate the short and long-term efficacy of a harm reduction intervention in reducing the use of non-clinical anabolic-androgenic steroids (AAS) in abusive users of AAS. As secondary objectives, the study will investigate the intervention's effect on health parameters (i.e., blood), quality of life, sleep quality, body image, eating behavior, depression, anxiety, fatigue, aggressiveness, cardiovascular parameters, muscle strength, body composition and muscle cross-sectional area outcomes.
Anyone over 15 years of age;
Planning to use/increase the dose of AAS for aesthetic and/or physical performance purposes;
Plan to use/increase the dose of AAS during eight to twelve weeks.
Medical prescription for AAS use;
Use for sexual reassignment.
University of Sao Paulo
Lead sponsor